| RS373160858 |
CHST6
|
Health Risk |
Conflicting classifications of pathogenicity |
Macular corneal dystrophy, CHST6-related disorder |
| RS373161548 |
DNM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate B, Inborn genetic diseases |
| RS373162171 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, ZNF469-related disorder |
| RS373162382 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Dystrophin deficiency |
| RS373163994 |
FANCM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia |
| RS373164247 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS373164723 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS373165011 |
PLOD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS373165304 |
CLCNKB
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 3, Bartter disease type 4B |
| RS373166152 |
NOTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS373167735 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Peutz-Jeghers syndrome |
| RS373168257 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS373168555 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS373168798 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, TTN-related disorder |
| RS373169150 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
TTN-related disorder, TTN-related disorder |
| RS373169422 |
MYO7A
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Usher syndrome type 1B |
| RS373169526 |
KRAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardio-facio-cutaneous syndrome, Cardiovascular phenotype |
| RS373170458 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS373172185 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS373172332 |
SLC12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 1, Bartter disease type 1 |
| RS373172640 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiomyopathy |
| RS373172891 |
L2HGDH
|
Health Risk |
Conflicting classifications of pathogenicity |
L-2-hydroxyglutaric aciduria, L2HGDH-related disorder |
| RS373173586 |
ARL13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 8, Joubert syndrome 8 |
| RS373173968 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS373174008 |
ERCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Cockayne syndrome type 1, Cockayne syndrome type 1 |
| RS373174326 |
SLC45A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculocutaneous albinism type 4, SLC45A2-related disorder |
| RS3731746 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset myopathy with fatal cardiomyopathy, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS373174786 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Inborn genetic diseases |
| RS3731753 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset myopathy with fatal cardiomyopathy, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS373175308 |
FBXL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 13, Mitochondrial DNA depletion syndrome 13 |
| RS373176089 |
SLC3A1
|
Health Risk |
Pathogenic |
Cystine urolithiasis, Cystine urolithiasis |
| RS373176644 |
INPP5E
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Joubert syndrome 1 |
| RS373177231 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS373177574 |
LAMA5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS373178636 |
FTL
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroferritinopathy, Hereditary hyperferritinemia with congenital cataracts |
| RS373178770 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS373178892 |
ATP1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemiplegic migraine, Inborn genetic diseases |
| RS373178978 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Transitory neonatal diabetes mellitus, Maturity-onset diabetes of the young |
| RS373179717 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS373180788 |
RECQL4
|
Health Risk |
Pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS373180876 |
ANKRD11
|
Health Risk |
Conflicting classifications of pathogenicity |
KBG syndrome, ANKRD11-related disorder |
| RS373181158 |
NTRK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary insensitivity to pain with anhidrosis, NTRK1-related disorder |
| RS373181939 |
SLC33A1
|
Health Risk |
Conflicting classifications of pathogenicity |
SLC33A1-related disorder, Inborn genetic diseases |
| RS373182062 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis |
| RS373182378 |
GUCY1A1
|
Health Risk |
Pathogenic |
Moyamoya disease with early-onset achalasia, Moyamoya disease 1 |
| RS373182673 |
ABCG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Sitosterolemia, Cardiovascular phenotype |
| RS373182816 |
LONP1
|
Health Risk |
Conflicting classifications of pathogenicity |
CODAS syndrome, LONP1-related disorder |
| RS373183462 |
MAGEL2
|
Health Risk |
Conflicting classifications of pathogenicity |
MAGEL2-related disorder, Inborn genetic diseases |
| RS373183802 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Autosomal recessive retinitis pigmentosa |
| RS373184762 |
DUT
|
Health Risk |
Likely pathogenic |
Bone marrow failure and diabetes mellitus syndrome, Bone marrow failure and diabetes mellitus syndrome |
| RS373184968 |
PLEKHG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease recessive intermediate C, Neuronopathy |
| RS373185353 |
DCHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS373186765 |
DPF2
|
Health Risk |
Pathogenic |
— |
| RS373186884 |
BMPR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary pulmonary hypertension, Inborn genetic diseases |
| RS373187237 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Rothmund-Thomson syndrome type 2 |
| RS373187583 |
CHRND
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal multiple pterygium syndrome, Congenital myasthenic syndrome 3B |
| RS373187796 |
CLCNKA
|
Health Risk |
Likely pathogenic |
Bartter disease type 4B, Bartter disease type 4B |
| RS373190026 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS373190270 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS373190423 |
SLC25A19
|
Health Risk |
Conflicting classifications of pathogenicity |
Amish lethal microcephaly, Amish lethal microcephaly |
| RS373190458 |
PYGM
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type V |
| RS373190681 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Hearing impairment |
| RS373190699 |
ADGRE2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS373191549 |
EXOSC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 1B, Pontocerebellar hypoplasia type 1B |
| RS373192520 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS373193482 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS373193953 |
KRT9
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS373196573 |
MBD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS373197206 |
FREM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculotrichoanal syndrome, Trigonocephaly 2 |
| RS373197800 |
HINT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive axonal neuropathy with neuromyotonia, Autosomal recessive axonal neuropathy with neuromyotonia |
| RS373197894 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa 25 |
| RS373198092 |
SLC19A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Biotin-responsive basal ganglia disease, Inborn genetic diseases |
| RS373198476 |
KCNJ1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bartter disease type 2, Bartter disease type 2 |
| RS373198570 |
MERTK
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, MERTK-related disorder |
| RS373198842 |
MMACHC
|
Health Risk |
Conflicting classifications of pathogenicity |
Disorders of Intracellular Cobalamin Metabolism, Cobalamin C disease |
| RS373198856 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, RAI1-related disorder |
| RS373199401 |
MYO6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 37, Autosomal dominant nonsyndromic hearing loss 22 |
| RS373200654 |
ABHD12
|
Health Risk |
Conflicting classifications of pathogenicity |
PHARC syndrome, PHARC syndrome |
| RS373201245 |
HNF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS373201488 |
ABCB11
|
Health Risk |
Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS373201651 |
RPGRIP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS373201722 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 11, Cardiomyopathy |
| RS373202198 |
IGF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Growth delay due to insulin-like growth factor type 1 deficiency, Growth delay due to insulin-like growth factor type 1 deficiency |
| RS373202724 |
FREM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculotrichoanal syndrome, Oculotrichoanal syndrome |
| RS373203204 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS373203286 |
KRT83
|
Health Risk |
Conflicting classifications of pathogenicity |
Monilethrix, Monilethrix |
| RS373203358 |
TRPM1
|
Health Risk |
Likely pathogenic |
— |
| RS373203368 |
VWF
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary von Willebrand disease, Hereditary von Willebrand disease |
| RS373203481 |
GCDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutaric aciduria, type 1 |
| RS373203896 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS373204179 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS373204728 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS373204984 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS373206096 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS373207084 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS373208120 |
CLRN1
|
Health Risk |
Pathogenic |
Usher syndrome type 3A, Retinitis pigmentosa 61 |
| RS373208457 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, PKHD1-related disorder |
| RS373208804 |
FBXO11
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS373209496 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS373210484 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |